Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

NCT01039597 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Ulcerative Colitis

Interventions

DRUG: ORE1001
DRUG: Placebo

Sponsor

Ore Pharmaceuticals, Inc.